Peculiarities of Etiotropic Therapy of Plague Infection Induced by Atypical Strains of F1- Phenotype Plague Microbe

Antibiotiki i Khimioterapiya

Volumn 43, Issue 9, 1998, Pages 24-28

  Ryzhko, I V ^a   Samokhodkina, F D ^a   Tsuraeva, R I ^a   Shcherbanyuk, A I ^a   Tsetskhladze, N S ^a  

^a Research Institute for Plague Control   (Russian Federation)

Author keywords

Antibiotic susceptibility; Experimental plague infection; Prophylaxis; Therapy

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAF1 PROTEIN, YERSINIA PESTIS; CEPHALOSPORIN DERIVATIVE; DOXYCYCLINE; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANIMAL; ARTICLE; DISEASE MODEL; GENETICS; IMMUNOLOGY; MOUSE; PHENOTYPE; PLAGUE;

AMINOGLYCOSIDES; AMPICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIBIOTICS, ANTITUBERCULAR; ANTIGENS, BACTERIAL; AZTREONAM; BACTERIAL PROTEINS; CEPHALOSPORINS; DISEASE MODELS, ANIMAL; DOXYCYCLINE; FLUOROQUINOLONES; MICE; MONOBACTAMS; PENICILLINS; PHENOTYPE; PLAGUE; RIFAMPIN;

EID: 0031610450     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Winter C C., Cherry W.B , Moody M.D. Bull WHO 1960; 23. 2-3: 408-409.
2. Williams I.E., Cavanaugh D.C. Experimentia 1984; 40: 739-740.
3. Paget I.E., Barnes J.M. Evaluation of drug activities. Pharmacometric. London 1964; 1 135-167.